Skip to main content
Clinical Trials/EUCTR2007-006099-12-DK
EUCTR2007-006099-12-DK
Active, not recruiting
Not Applicable

Oral treatment of allergy with a non-pathogenic microorganism: A randomised clinical trial - TSO-01

Statens Serum Institut0 sitesNovember 20, 2007

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Allergic rhinitis
Sponsor
Statens Serum Institut
Status
Active, not recruiting
Last Updated
14 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
November 20, 2007
End Date
TBD
Last Updated
14 years ago
Study Type
Interventional clinical trial of medicinal product
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • 1\.Male or female, aged \>18 and \<65 years
  • 2\.Symptoms of birch and/or grass pollen allergy the last 2 pollen seasons, or more.
  • 3\.Forced Expiratory Volume 1 \>70% of expected.
  • 4\.Scoring all symptoms of allergic rhinitis \>50 mm on a 100 mm VAS (0\=not bothersome, 10\=worst)
  • 5\.Specific IgE class \>2 to birch and/or grass (\>0\.7 kUallergen/l)
  • 6\.A positive skin prick test (\>3mm) to birch and/or grass
  • 7\.Women must not be pregnant, and women in fertile age must have a negative pregnancy test, not be breastfeeding, and use birth control during the trial unless sterile or post meno\-pausal
  • 8\.Prepared to grant authorized persons access to medical records
  • 9\.The volunteer is likely to comply with instructions
  • Are the trial subjects under 18? no

Exclusion Criteria

  • 1\.Significant asthma
  • 2\.Use of systemic steroids during the last 2 months
  • 3\.Immune therapy for birch or grass pollen allergy the last 2 years, or more.
  • 4\.Planning a travel abroad during the trial period (excluding areas with a similar grass/birch pollen counts when compared with the Copenhagen area)
  • 5\.Past or current severe diseases (a history of active hepatitis B or C, cytomegalovirus, herpes simplex, HIV, other kinds of immune deficiency, and cancer)
  • 6\.Anti\-helminth treatment within the last 2 weeks (e.g mebendazol)
  • 7\.Known or possible hypersensitivity to Trichuris species or compounds made of Trichuris species
  • 8\.A past or recent drug abuse
  • 9\.Participation in other clinical trials
  • 10\.Employed with the Investigator (Pulmonology\- and Allergy Clinic Copenhagen (center of trial)), or the relevant department at the sponsor institution (Department of Epidemiology Research at Statens Serum Institut).

Outcomes

Primary Outcomes

Not specified

Similar Trials